Mature tertiary lymphoid structures support B cell-mediated antitumour immunity and are disrupted by neoadjuvant therapy in rectal cancer: a multicentre, retrospective study
Authors:
Open Access
- 20 November 2025
- journal article
- Published by Elsevier in EBioMedicine
- Vol. 122, 106030
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Beijing Municipality (5156ZE1X)
- Peking Union Medical College Hospital
This publication has 35 references indexed in Scilit:
- Tertiary Lymphoid Structure in Dental Pulp: The Role in Combating Bacterial InfectionsAdvanced Science, 2024
- Radiation drives tertiary lymphoid structures to reshape TME for synergized antitumour immunityExpert Reviews in Molecular Medicine, 2024
- First in human intraarterial delivery of tislelizumab for the treatment of pMMR locally advanced rectal cancer: A single-arm, open label, phase II clinical trialTranslational Oncology, 2024
- CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasisCancer Cell, 2024
- Tertiary lymphoid structures in anticancer immunityNature Reviews Cancer, 2024
- The roles of tertiary lymphoid structures in chronic diseasesNature Reviews Nephrology, 2023
- B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcomeNature Reviews Clinical Oncology, 2022
- Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancerImmunity, 2022
- Neoadjuvant Chemotherapy Increases Cytotoxic T Cell, Tissue Resident Memory T Cell, and B Cell Infiltration in Resectable NSCLCJournal of Thoracic Oncology, 2021
- Fast, sensitive and accurate integration of single-cell data with HarmonyNature Methods, 2019